Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110475 · Cited by 1,027

Viral myocarditis—diagnosis, treatment options, and current controversies

Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657

Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices — United States, June 2021

Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., Broder, K. R., Gee, J., Weintraub, E., Shimabukuro, T., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7027e2 · Cited by 587

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

Daugherty, S. E., Guo, Y., Heath, K., Dasmariñas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., & Cohen, K. (2021) · BMJ · doi:10.1136/bmj.n1098 · Cited by 437

Computing Adjusted Risk Ratios and Risk Differences in Stata

Norton, E. C., Miller, M. M., & Kleinman, L. C. (2013) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1301300304 · Cited by 299

What's the Risk? A Simple Approach for Estimating Adjusted Risk Measures from Nonlinear Models Including Logistic Regression

Kleinman, L. C., & Norton, E. C. (2008) · Health Services Research · doi:10.1111/j.1475-6773.2008.00900.x · Cited by 287

Myocarditis associated with Covid‐19 disease: A systematic review of published case reports and case series

Rathore, S. S., Rojas, G. A., Sondhi, M., Pothuru, S., Pydi, R., Kancherla, N., Singh, R., Ahmed, N. K., Shah, J., Tousif, S., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14470 · Cited by 83

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

Murk, W. K., Gierada, M., Fralick, M., Weckstein, A. R., Klesh, R., & Rassen, J. A. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.201686 · Cited by 64

Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-Like Syndrome in Adults

Most, Z. M., HENDREN, N. S., Drazner, M. H., & Perl, T. M. (2020) · Circulation · doi:10.1161/circulationaha.120.050166 · Cited by 49

Differences Between Pediatric Acute Myocarditis Related and Unrelated to SARS-CoV-2

Vukomanovic, V. A., Krasić, S., Prijić, S., Ninić, S., Minic, P. B., Petrović, G., & Nešić, D. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003094 · Cited by 28

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Oster, M. E., Shay, D. K., Su, J. R., Gee, J. M., Creech, C. B., Broder, K. R., Edwards, K. M., Soslow, J. H., Dendy, J. M., Schlaudecker, E. P., et al. (2022) · JAMA · doi:10.1001/jama.2021.24110 · Cited by 686

2025 ESC Guidelines for the management of myocarditis and pericarditis

Schulz‐Menger, J., Collini, V., Gröschel, J., Adler, Y., Brucato, A. L., Christian, V., Ferreira, V. M., Gandjbakhch, E., Heidecker, B., Kernéis, M., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf192 · Cited by 563

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play

Gluckman, T. J., Bhave, N. M., Allen, L. A., Chung, E. H., Spatz, E. S., Ammirati, E., Baggish, A. L., Bozkurt, B., Cornwell, W. K., Harmon, K. G., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.003 · Cited by 431

COVID-19, Myocarditis and Pericarditis

Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis

Ling, R. R., Ramanathan, K. R., Tan, F. L., Tai, B. C., Somani, J., Fisher, D. A., & MacLaren, G. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00059-5 · Cited by 168

Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022

Kompaniyets, L., Bull–Otterson, L., Boehmer, T. K., Baca, S., Alvarez, P., Hong, K., Hsu, J., Harris, A. M., Gundlapalli, A. V., & Saydah, S. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7131a3 · Cited by 161

Myocarditis Following COVID-19 Vaccine: Incidence, Presentation, Diagnosis, Pathophysiology, Therapy, and Outcomes Put Into Perspective. A Clinical Consensus Document Supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

Heidecker, B., Dagan, N., Balicer, R., Eriksson, U., Rosano, G., Coats, A., Tschöpe, C., Kelle, S., Poland, G. A., Frustaci, A., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2669 · Cited by 159

Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada

Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., Calzavara, A., Lu, D., Harris, T. M., Yu, K., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.18505 · Cited by 157

Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents

Rao, S., Lee, G. M., Razzaghi, H., Lorman, V., Mejías, A., Pajor, N. M., Thacker, D., Webb, R. D., Dickinson, K., Bailey, L. C., et al. (2022) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.2800 · Cited by 152

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022

Block, J. P., Boehmer, T. K., Forrest, C. B., Carton, T. W., Lee, G. M., Ajani, U. A., Christakis, D., Cowell, L. G., Draper, C., Ghildayal, N., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7114e1 · Cited by 152

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine

Lai, F. T. T., Li, X., Peng, K., Huang, L., Ip, P., Tong, X., Chui, C. S. L., Wan, E. Y. F., Wong, C. K. H., Chan, E. W., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-3700 · Cited by 143

Should children be vaccinated against COVID-19?

Zimmermann, P., Pittet, L. F., Finn, A. H. R., Pollard, A. J., & Curtis, N. C. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2021-323040 · Cited by 131

Impact of COVID-19 on Cardiovascular Disease

Vosko, I., Zirlik, A., & Bugger, H. (2023) · Viruses · doi:10.3390/v15020508 · Cited by 139

Long Covid: where we stand and challenges ahead

Mantovani, A., Morrone, M. C., Patrono, C., Santoro, M., Schiaffino, S., Remuzzi, G., Bussolati, G., On behalf of the Covid-19 Commission of the Accademia Nazionale dei Lincei, Cappuccinelli, P., Fitzgerald, G., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01052-6 · Cited by 124

mRNA vaccines for COVID-19 and diverse diseases

Hussain, A., Yang, H., Zhang, M., Liu, Q., Alotaibi, G., Irfan, M. F., He, H., Chang, J. K., Liang, X., Weng, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.032 · Cited by 121

Mechanisms underlying sex differences in autoimmunity

Fairweather, D., Beetler, D. J., McCabe, E. J., & Lieberman, S. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180076 · Cited by 121

The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury

Siripanthong, B., Asatryan, B., Hanff, T. C., Chatha, S., Khanji, M. Y., Ricci, F., Muser, D., Ferrari, V. A., Nazarian, S., Santangeli, P., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.10.011 · Cited by 102

Viral Myocarditis: Classification, Diagnosis, and Clinical Implications

Sozzi, F. B., Gherbesi, E., Faggiano, A., Gnan, E., Maruccio, A., Schiavone, M., Iacuzio, L., & Carugo, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.908663 · Cited by 109

Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis

Voleti, N., Reddy, S. P., & Ssentongo, P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.951314 · Cited by 98

Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician

Tobler, D. L., Pruzansky, A. J., Naderi, S., Ambrosy, A. P., & Slade, J. J. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01032-8 · Cited by 98

Myocarditis associated with COVID-19 vaccination

Buoninfante, A., Andeweg, A. C., Genov, G., & Cavaleri, M. (2024) · npj Vaccines · doi:10.1038/s41541-024-00893-1 · Cited by 81

Risk of Myocarditis and Pericarditis Following BNT162b2 and mRNA-1273 COVID-19 Vaccination

Goddard, K., Lewis, N., FIREMAN, B. H., Weintraub, E., Shimabukuro, T. T., Zerbo, O., Boyce, T. G., Oster, M. E., Hanson, K. E., Donahue, J. G., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.07.007 · Cited by 70

BNT162b2 Vaccine‐Associated Myo/Pericarditis in Adolescents: A Stratified Risk‐Benefit Analysis

Krug, A., Stevenson, J., & Høeg, T. B. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13759 · Cited by 69

COVID-19 Pathogenesis and Clinical Manifestations

Acosta, R. A. H., Garrigos, Z. E., Marcelin, J. R., & Vijayvargiya, P. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.01.003 · Cited by 71

SARS-CoV-2 infection in children and implications for vaccination

Nathanielsz, J., Toh, Z. Q., Do, L. A. H., Mulholland, K., & Licciardi, P. V. (2022) · Pediatric Research · doi:10.1038/s41390-022-02254-x · Cited by 67

TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells

Rolski, F., Tkacz, K., Węglarczyk, K., Kwiatkowski, G., Pelczar, P., Jaźwa, A., Bar, A., Kuster, G. M., Chłopicki, S., Siedlar, M., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad158 · Cited by 59

Clinical course and management of COVID-19 in the era of widespread population immunity

Meyerowitz, E. A., Scott, J. A., Richterman, A. G., Male, V. H., & Çevik, M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-01001-1 · Cited by 52

Cardiovascular Complications of Coronavirus Disease-2019

Terzic, C. M., & Medina‐Inojosa, B. J. (2023) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2023.03.003 · Cited by 52

Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview

Gupta, A., Marzook, H., & Ahmad, F. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00821-4 · Cited by 58

Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID‐19 vaccine

Woo, W., Kim, A. Y., Yon, D. K., Lee, S. W., Hwang, J., Jacob, L., Koyanagi, A., Kim, M. S., Moon, D. H., Jung, J. W., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27501 · Cited by 50

COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review

Jaiswal, V., Sarfraz, Z., Sarfraz, A., Mukherjee, D., Batra, N., Hitawala, G., Yaqoob, S., Patel, A., Agarwala, P., Ruchika, F., et al. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211056800 · Cited by 48

The impact of COVID-19 and COVID vaccination on cardiovascular outcomes

Akhtar, Z., Trent, M. J., Moa, A., Tan, T. C., Fröbert, O., & MacIntyre, C. R. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac123 · Cited by 53

A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection

Branche, A. R., Ramesh, M. S., & Francis, B. M. (2024) · Infectious Diseases and Therapy · doi:10.1007/s40121-024-01081-3 · Cited by 49

Diagnosis and management of post-COVID (Long COVID) in children: a moving target

Morello, R., Martino, L., & Buonsenso, D. (2023) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001221 · Cited by 47

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis

Alami, A., Krewski, D., Farhat, N., Mattison, D., Wilson, K., Gravel, C. A., Farrell, P. J., Crispo, J. A. G., Haddad, N., Perez-Lloret, S., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065687 · Cited by 44

Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England

Nafilyan, V., Bermingham, C. R., Ward, I. L., Morgan, J., Zaccardi, F., Khunti, K. K., Stanborough, J., Banerjee, A., & Doidge, J. (2023) · Nature Communications · doi:10.1038/s41467-023-36494-0 · Cited by 49

Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines

Abraham, N., Spruin, S., Rossi, T. M., FIREMAN, B. H., Zafack, J. G., Blaser, C., Shaw, A. K., Hutchings, K., & Ogunnaike-Cooke, S. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.05.048 · Cited by 45

Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020

Moll, K., Lufkin, B., Fingar, K. R., Zhou, C. K., Tworkoski, E., Shi, C., Hobbi, S., Hu, M., Sheng, M., McCarty, J., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.11.003 · Cited by 40

Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study

Naveed, Z., Li, J., Spencer, M., Wilton, J., Naus, M., García, H. A. V., Otterstatter, M. C., & Janjua, N. Z. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.220676 · Cited by 42

Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis

Gurdasani, D., Bhatt, S., Costello, A. M. D. L., Denaxas, S., Flaxman, S. R., Greenhalgh, T., Griffin, S. D. C., Hyde, Z., Katzourakis, A., McKee, M., et al. (2021) · Journal of the Royal Society of Medicine · doi:10.1177/01410768211052589 · Cited by 41

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide

Straus, W., Urdaneta, V., Esposito, D. B., Mansi, J. A., Sanz Rodriguez, C., Burton, P., & Vega, J. M. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac446 · Cited by 41

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis

Du, Y., Chen, L., & Shi, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.829176 · Cited by 45

Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Copland, E., Patone, M., Saatci, D., Handunnetthi, L., Hirst, J. A., Hunt, D. P. J., Mills, N. L., Moss, P. A. H., Sheikh, A., Coupland, C. A. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47745-z · Cited by 40

Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents

Wu, Q., Tong, J., Zhang, B., Zhang, D., Chen, J., Lei, Y., Lu, Y., Wang, Y., Li, L., Shen, Y., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m23-1754 · Cited by 36

Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents

Blatz, A. M., & Randolph, A. G. (2022) · Critical Care Clinics · doi:10.1016/j.ccc.2022.01.005 · Cited by 37

Acute Cardiac Events During COVID-19-Associated Hospitalizations

Woodruff, R. C., Garg, S., George, M. G., Patel, K., Jackson, S. L., Loustalot, F. V., Wortham, J. M., Taylor, C. A., WHITAKER, M. D., Reingold, A. L., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.044 · Cited by 36

COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19

Sapir, T., Averch, Z., Lerman, B., Bodzin, A., Fishman, Y., & Maitra, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158606 · Cited by 34

Myocarditis associated with COVID-19 and its vaccines - a systematic review

Rout, A., Suri, S. S., Vorla, M., & Kalra, D. K. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.10.004 · Cited by 38

Myocarditis: A complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology

Szarpak, L., Pruc, M., Filipiak, K. J., Popieluch, J., Bielski, A., Jaguszewski, M. J., Gilis-Malinowska, N., Chirico, F., Rafique, Z., & Peacock, F. W. (2021) · Cardiology Journal · doi:10.5603/cj.a2021.0155 · Cited by 33

Multimodality Imaging of Constrictive Pericarditis: Pathophysiology and New Concepts

Sohal, S., Mathai, S. V., Lipat, K., Kaur, A., Visveswaran, G. K., Cohen, M. C., Waxman, S., Tiwari, N., & Vucic, E. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01758-6 · Cited by 33

Cardiac Complications Associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination

Chin, S. E., Bhavsar, S. M., Corson, A., Ghersin, Z. J., & Kim, H. S. (2022) · Pediatric Cardiology · doi:10.1007/s00246-022-02851-x · Cited by 31

Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations

Power, J. R., Keyt, L. K., & ADLER, E. D. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2066522 · Cited by 32

Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health records

Zhang, B., Thacker, D., Zhou, T., Zhang, D., Lei, Y., Chen, J., Chrischilles, E. A., Christakis, D., Fernández, S., Garg, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56284-0 · Cited by 29

SARS-CoV-2 Infection and COVID-19 in Children

Waghmare, A., & Hijano, D. R. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.11.014 · Cited by 32

Epidemiological characterization of SARS-CoV-2 variants in children over the four COVID-19 waves and correlation with clinical presentation

Alteri, C., Scutari, R., Costabile, V., Colagrossi, L., Rosa, K. Y. L., Agolini, E., Lanari, V., Chiurchiù, S., Romani, L., Markowich, A. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14426-0 · Cited by 28

Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic

Vidal-Pérez, R., Brandao, M., Pazderník, M., Kresoja, K., Carpenito, M., Maeda, S., Casado-Arroyo, R., Muscoli, S., Pöss, J., Fontes‐Carvalho, R., et al. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i27.9556 · Cited by 29

The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States

Kohli, M. A., Maschio, M., Joshi, K., Lee, A., Fust, K., Beck, E. C., de Velde, N. V., & Weinstein, M. C. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2281083 · Cited by 26

Cardiovascular effects of the post-COVID-19 condition

Goerlich, E., Chung, T., Hong, G. H., Metkus, T. S., Gilotra, N. A., Post, W. S., & Hays, A. G. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00414-8 · Cited by 27

COVID-19 Associated Myocarditis Clinical Outcomes among Hospitalized Patients in the United States: A Propensity Matched Analysis of National Inpatient Sample

Davis, M. G., Bobba, A., Chourasia, P., Gangu, K., Shuja, H., Dandachi, D., Farooq, A., Avula, S. R., Shekhar, R., & Sheikh, A. B. (2022) · Viruses · doi:10.3390/v14122791 · Cited by 25

Role of immune cells in the pathogenesis of myocarditis

Liu, K., & Han, B. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad143 · Cited by 34

Current Treatment and Immunomodulation Strategies in Acute Myocarditis

Ferone, E., Segev, A., Tempo, E., Gentile, P., Elsanhoury, A., Baggio, C., Artico, J., Bhatti, P., Scott, P. A., Bobbio, E., et al. (2024) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001542 · Cited by 29

Incidence and risk factors of myocarditis in hospitalized patients with COVID‐19

Keller, K., Sagoschen, I., Konstantinides, S., Gori, T., Münzel, T. F., & Hobohm, L. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28646 · Cited by 23

Myocarditis mortality with and without COVID-19: insights from a national registry

Bemtgen, X., Kaier, K., Rilinger, J., Rottmann, F., Supady, A., von zur Mühlen, C., Westermann, D., Wengenmayer, T., & Staudacher, D. L. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02141-9 · Cited by 23

COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)

Chary, M. A., Barbuto, A. F., Izadmehr, S., Tarsillo, M., Fleischer, E., & Burns, M. M. (2023) · Journal of Medical Toxicology · doi:10.1007/s13181-023-00931-9 · Cited by 24

SARS-CoV-2 infection and immune responses

Harne, R., Williams, B., Abdelaal, H. F. M., Baldwin, S. L., & Coler, R. N. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023015 · Cited by 21

COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports

Urban, S., Fułek, M., Błaziak, M., Iwanek, G., Jura, M., Fułek, K., Guzik, M., Garus, M., Gajewski, P., Lewandowski, Ł., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195519 · Cited by 23

Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021

Schieber, L. Z., Dunphy, C., Schieber, R. A., Lopes-Cardozo, B., Moonesinghe, R., & Guy, G. P. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.5047 · Cited by 22

Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection

Zhang, C., Verma, A., Feng, Y., Melo, M. C. R., McQuillan, M. A., Hansen, M. E. B., Lucas, A., Park, J., Ranciaro, A., Thompson, S. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123000119 · Cited by 20

Effects of COVID-19 on Arrhythmia

Zhan, Y., Yue, H., Liang, W., & Wu, Z. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9090292 · Cited by 21

Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review

Almas, T., Rehman, S., Mansour, E. Z., Khedro, T., Alansari, A., Malik, J., Alshareef, N., Nagarajan, V. R., Al-Awaid, A. H., Alsufyani, R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112843 · Cited by 19

Vaccines against Group B Coxsackieviruses and Their Importance

Mone, K., Lasrado, N., Sur, M., & Reddy, J. (2023) · Vaccines · doi:10.3390/vaccines11020274 · Cited by 22

COVID-19 and its long-term impact on the cardiovascular system

Philip, B., Mukherjee, P., Khare, Y., Ramesh, P., Zaidi, S., Sabry, H., & Harky, A. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2184800 · Cited by 19

COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors

Pannucci, P., Jefferson, S. R., Hampshire, J., Cooper, S. L., Hill, S. J., & Woolard, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065374 · Cited by 21

Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis

Ishisaka, Y., Watanabe, A., Aikawa, T., Kanaoka, K., Takagi, H., Wiley, J., Yasuhara, J., & Kuno, T. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131401 · Cited by 19

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data

van den Ouweland, F., Charpentier, N., Türeci, Ö., Rizzi, R., Mensa, F., Lindemann, C., & Pather, S. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2315659 · Cited by 20

Long COVID-19 Myocarditis and Various Heart Failure Presentations: A Case Series

Rohun, J., Dorniak, K., Faran, A., Kochańska, A., Zacharek, D., & Daniłowicz‐Szymanowicz, L. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120427 · Cited by 19

Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review

Yugar‐Toledo, J. C., Yugar, L. B. T., Sedenho‐Prado, L. G., Schreiber, R., & Moreno, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1162837 · Cited by 18

COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond

Fraser, M., Agdamag, A. C., Maharaj, V., Mutschler, M. S., Charpentier, V., Chowdhury, M., & Alexy, T. (2022) · Biology · doi:10.3390/biology11040520 · Cited by 18

Edukasi Gizi Seimbang Menggunakan Media Video terhadap Pengetahuan dan Sikap Mahasiswa di Masa Pandemi Covid-19

Suprapto, S., Mulat, T. C., & Hartaty, H. (2022) · Jurnal Keperawatan Profesional (KEPO) · doi:10.36590/kepo.v3i1.303 · Cited by 17

Global burden of myocarditis from 1990 to 2021: findings from the Global Burden of Disease Study 2021

Li, J., Fan, H., Yang, Y., Huang, Z., Yuan, Y., & Liang, B. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04402-z · Cited by 17

Long-term cardiac surveillance and outcomes of COVID-19 patients

Mitrani, R. D., Dabas, N., Alfadhli, J., Lowery, M. H., Best, T. M., Hare, J. M., Myerburg, R. J., & Goldberger, J. J. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.06.003 · Cited by 17

Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273

Urdaneta, V., Esposito, D. B., Dharia, P., Moraga, M. S., Anteyi, K., Oduyebo-Omotosho, T., Rossi, M., Burton, P. R., Vega, J. M., Dawson, R. S., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae067 · Cited by 18

The Cardiovascular Manifestations of COVID-19

Louis, D. W., Saad, M. S., Vijayakumar, S., Ilyas, S., Kokkirala, A. R., & Aronow, H. D. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.03.001 · Cited by 16

Nephrotic Syndrome in Adult Patients With COVID-19 Infection or Post COVID-19 Vaccine: A Systematic Review

Cancarevic, I., Nassar, M., Medina, L., Sanchez, A., Parikh, A., Hosna, A., Devanabanda, B., Vest, M., Ayotunde, F., Ghallab, M., et al. (2022) · Cureus · doi:10.7759/cureus.29613 · Cited by 16

Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children

Chow, E. J., & Englund, J. A. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.01.005 · Cited by 21

Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital

Urroz, M., Guijarro-Eguinoa, J., Huertas, A. G. L. D. L., Jiménez-González, M., & Ramı́rez, E. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116181 · Cited by 16

A case of fulminant myocarditis due to COVID‐19 in an adolescent patient successfully treated with venous arterial ECMO as a bridge to recovery

Buitrago, D., Munoz, J., Finkelstein, E. R., & Mulinari, L. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16313 · Cited by 14

Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population

Frasca, L., Ocone, G., & Palazzo, R. (2023) · Pathogens · doi:10.3390/pathogens12020233 · Cited by 18

Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study

McKinnon, J. E., Wang, D. D., Zervos, M., Saval, M., Marshall-Nightengale, L., Kilgore, P. E., Pabla, P., Szandzik, E. G., Maksimowicz‐McKinnon, K., & O’Neill, W. W. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.12.343 · Cited by 14

Meta-analysis of the impact of physical activity on the recovery of physical function in COVID-19 patients

Yang, G., Li, Z., Li, Z., Huang, L., Liang, P., Liu, L., & Li, D. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19339 · Cited by 15

Case Report: Myocarditis After COVID-19 Vaccination – Case Series and Literature Review

Nunn, S., Kersten, J., Tadić, M., Wolf, A., Gonska, B., Hüll, E., Dietenberger, H., Rottbauer, W., & Buckert, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.836620 · Cited by 13

Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement

Palmisano, A., Gambardella, M., D’Angelo, T., Vignale, D., Ascione, R., Gatti, M., Peretto, G., Federico, F., Shah, A. B., & Esposito, A. (2022) · Clinical Imaging · doi:10.1016/j.clinimag.2022.07.009 · Cited by 13

Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae

Panagiotides, N. G., Poledniczek, M., Andreas, M., Hülsmann, M., Kocher, A. A., Kopp, C. W., Piechota-Polańczyk, A., Weidenhammer, A., Pávó, N., & Wadowski, P. P. (2024) · Viruses · doi:10.3390/v16010121 · Cited by 12

COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment

Qiu, H., Li, J., Li, J., Li, H., & Xin, Y. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01902-w · Cited by 12

Mortality Prediction of COVID-19 in Hospitalized Patients Using the 2020 Diagnosis Procedure Combination Administrative Database of Japan

Nojiri, S., Irie, Y., Kanamori, R., Naito, T., & Nishizaki, Y. (2022) · Internal Medicine · doi:10.2169/internalmedicine.0086-22 · Cited by 12

Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection

Shahbaz, S., Oyegbami, O., Saito, S., Osman, M. S., Sligl, W., & Elahi, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021928 · Cited by 12

Heart disease prediction with a feature-sensitized interpretable framework for the Internet of Medical Things sensors

Kailasanathan, N., Ezhilarasan, G., Selvarajan, S., Dhanaraj, R. K., Pamucar, D., & Shankar, N. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1612915 · Cited by 18

COVID-19 and myocarditis: a brief review

Taher, F., Eysa, A., Fahmy, D. M., Shalaby, A. M., Mahmoud, A. H., El-Melegy, M., Razek, A. A. K. A., & El-Baz, A. S. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2702073 · Cited by 11

mRNA-based COVID-19 Vaccines Booster Dose: Benefits, Risks and Coverage.

Nashwan, A. J., Yassin, M. A., Soliman, A. T., Sanctis, V. D., & Ibrahim, M. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i3.13103 · Cited by 11

Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology

Hamedi, K. R., Loftus, G., Traylor, L. B., Goodwin, R. L., & Arce, S. (2023) · Vaccines · doi:10.3390/vaccines11020362 · Cited by 13

Myocarditis And COVID-19: An Analysis Of All Claims Administrative Data From Before And During The Pandemic

Zadeh, A. V., Wong, A., Collado, E., & Larned, J. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.10.113

Incidence and risk factors of myocarditis in hospitalized patients with COVID‐19

Keller, K., Sagoschen, I., Konstantinides, S., Gori, T., Münzel, T. F., & Hobohm, L. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28646 · Cited by 23

Incidence and risk factors of myocarditis in hospitalized patients with COVID-19 in Germany

Keller, K., Sagoschen, I., Konstantinides, S., Gori, T., Münzel, T. F., & Hobohm, L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad655.1820

Hospitalisations with myocarditis before and during the COVID-19 pandemic – a nationwide cohort study

Héritier, J., Laager, R., Schelldorfer, A., Gregoriano, C., Müeller, B., Schüetz, P., & Kutz, A. (2026) · Swiss Medical Weekly · doi:10.57187/4794

The Impact of COVID‐19 Infection and Vaccination on Myocarditis Incidence: A Comparative Analysis of Pre‐, Peri‐, and Post‐Pandemic Eras

Waksman, O., Abusnina, W. A., Case, B. C., Cellamare, M., Zhang, C., Rappaport, H., Sawant, V., THAKKAR, Y., & Waksman, R. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70659